Section Arrow
XENE.NASDAQ
- Xenon Pharmaceuticals
Quotes are at least 15-min delayed:2026/06/10 08:19 EDT
Pre Market
Last
 52.4
-0.39 (-0.74%)
Bid
51.32
Ask
53.5
High 53.51 
Low 52.31 
Volume 474 
Regular Hours (Closed)
Last
 52.79
+1.58 (+3.09%)
Day High 
52.87 
Prev. Close
51.21 
1-M High
57.27 
Volume 
1.43M 
Bid
51.32
Ask
53.5
Day Low
51.33 
Open
52.14 
1-M Low
50.91 
Market Cap 
4.95B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 53.25 
20-SMA 54.01 
50-SMA 55.79 
52-W High 63.95 
52-W Low 30 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.70/-4.79
Enterprise Value
4.96B
Balance Sheet
Book Value Per Share
13.84
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
7.50M
Operating Revenue Per Share
0.00
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ADTXAditxt Inc.0.0289-0.021-42.08%-- 
Pre Market 0.0204 -0.0085 -29.41%
NUVLNuvalent123.25+34.76+39.28%-- 
Pre Market 123.1 -0.15 -0.12%
RXRXRecursion Pharmaceuticals3.22-0.1-3.01%-- 
Pre Market 3.1295 -0.0905 -2.81%
GERNGeron Corp1.12-0.01-0.88%-- 
Pre Market 1.1113 -0.0087 -0.78%
GOSSGossamer Bio0.16-0.0056-3.38%-- 
Pre Market 0.1607 +0.0007 +0.44%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.